VTRS · 10-Q · 2026Q3 · Full report
Accrued Legal and Regulatory
Viatris Inc · 2026-11-05 · Importance 38 · Surprise 24 · Contradicted
Viatris reported approximately $459 million accrued for legal contingencies as of September 30, 2026, and said it faces disputes, governmental or regulatory inquiries, investigations, proceedings, and litigation in the U.S. and abroad. The company disclosed a dispute with Pfizer over a requested payment under an agreement requiring Viatris to pay Pfizer 57% of specified opioid-related third-party losses incurred since July 29, 2019; Viatris disputes that the requested amount is owed. The filing says an unfavorable outcome in ongoing matters could materially affect the company’s business, financial condition, results, cash flows, ability to pay dividends or repurchase shares, or stock price.
Key facts
- Viatris generally assumed liability for and control of pending and threatened legal matters relating to the Upjohn Business and agreed to indemnify Pfizer for liabilities arising from those matters. source
- Viatris had approximately $459 million accrued for legal contingencies at September 30, 2026. source
- Viatris agreed to pay Pfizer 57% of losses actually incurred or suffered by Viatris, its predecessors or subsidiaries since July 29, 2019, from third-party actions concerning opioid manufacture, distribution, marketing, promotion or sale by or on their behalf. source
- In June 2026, Viatris received a letter from Pfizer inquiring about Viatris' plan for payment under the opioid-loss agreement; Viatris disputes that the requested payment is owed. source
- Viatris' total litigation settlements and other contingencies, net, were an expense of $115.7 million for the nine months ended September 30, 2026, compared with a $65.4 million gain in the prior-year period. source
- Viatris' litigation settlements and other contingencies, net, were $115.7 million for the nine months ended September 30, 2026 and a gain of $65.4 million for the comparable 2025 period. source
- Third-quarter 2026 litigation settlements and other contingencies, net, were a gain of $11.0 million, including a $17.5 million contingent consideration adjustment loss reversal and $6.5 million of litigation settlements expense. source
- Viatris recognized net litigation settlement losses of $27.5 million for the nine months ended September 30, 2026, compared with $84.9 million in the prior-year period. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| liability | negative | realized | -1.3% | Viatris had approximately $459 million accrued for legal contingencies at September 30, 2026. |
| liability | negative | contingent | — | Viatris generally assumed liability for and control of pending and threatened legal matters relating to the Upjohn Business and agreed to… |